Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Anuh Pharma Ltd. Share Price
Day's Range
Day's Range
Low
₹79.70
High
₹82.35
Price Summary
| Previous Close | ₹81.10 |
|---|---|
| Day's Range | ₹79.70 - ₹82.35 |
| Open | ₹80.75 |
| 52 Week Range | ₹67.00 - ₹93.00 |
| Volume | 80,373 |
| Market Cap | ₹0.00 |
| Previous Close | ₹81.24 |
|---|---|
| Day's Range | ₹79.80 - ₹82.50 |
| Open | ₹81.27 |
| 52 Week Range | ₹66.72 - ₹93.00 |
| Volume | 7,557 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 65.39 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 1.85 |
| Price/Earning (TTM) | 18.43 |
| TTM EPS (₹) | 4.41 |
| P/E Ratio | 16.39 |
| Book Value(₹) | 2.24 |
| PAT Margin (%) | 5.27 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 16.02 |
| Trade Value ( ₹ in Lacs) | 6.13 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 1.85 |
| Price/Earning (TTM) | 18.43 |
| TTM EPS (₹) | 4.41 |
| P/E Ratio | 16.39 |
| Book Value(₹) | 2.24 |
| PAT Margin (%) | 5.27 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 16.02 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 1864.79 | 6615.15 |
| Expenses | N/A | N/A |
| PBT | 109.53 | 610.05 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 83.01 | 473.52 |
About Anuh Pharma Ltd.
| Founded | 1960 |
|---|---|
| NSE Symbol | ANUHPHR |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,55,633.71 | 1,899.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,41,576.41 | 9,100.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,84,478.41 | 4,850.00 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,24,661.30 | 8,670.00 | 6,696.50 - 6,696.50 |
| Lenskart Solutions Ltd. | 1,18,977.24 | 684.05 | 0.00 - 0.00 |
| Cipla Ltd. | 1,11,888.39 | 1,385.00 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,11,820.18 | 1,121.00 | 835.50 - 835.50 |
| Laurus Labs Ltd. | 99,417.45 | 1,840.00 | 823.10 - 823.10 |
| Lupin Ltd. | 96,528.82 | 2,111.00 | 1,900.00 - 1,900.00 |
| Dr. Reddy's Laboratories Ltd. | 96,322.06 | 1,154.00 | 1,101.00 - 1,101.00 |
No Records Found
Latest News
Emmessar Biotech & Nutrition informs about newspaper add
SMS Pharmaceuticals informs about newspaper advertisement
Pursuant to Regulations 30 and 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, SMS Pharmaceuticals has informed that it enclosed copies of the newspaper advertisement published on 5th September, 2026, intimating the dispatch of Notice of 38th Annual General Meeting and Integrated Annual Report for the financial year 2025-2026 for convening the 38th Annual General Meeting to be held on Tuesday, 29th September, 2026 at 10.30 AM (IST) through Video Conferencing or Other Audio Visual Means, without physical presence of the members at a common venue, in compliance with the Circular Nos. 14/2020, 17/2020, 20/2020, 02/2021, 21/2021, 2/2022, 10/2022, 09/2023, 09/2024 and 03/2025 dated 08th April, 2020, 13th April, 2020, 05th May, 2020, 13th January, 2021, 14th December, 2021, 05th May, 2022, 28th December, 2022, 25th September 2023, 19th September, 2024 and 22nd September, 2025 (collectively referred to as ‘MCA Circulars’) and Securities and Exchange Board of India. The advertisement has published in the newspapers: Financial Express (in English language) and Nava Telangana (in Telugu language). The newspaper advertisements are also made available on the website of the Company www.smspharma.com at Investors section.
Aster DM Quality Care informs about integrated annual report
Aster DM Quality Care submits integrated annual report and AGM notice
In compliance with Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aster DM Quality Care has informed that it enclosed the Integrated Annual Report of the company for the Financial Year 2025-26 along with Notice of the 18th Annual General Meeting (‘AGM’) being held on Monday, 28 September 2026, at 11.30 AM (IST) through Video Conferencing (‘VC’) facility / Other Audio Visual Means (‘OAVM’), to transact the businesses as set forth in the Notice of AGM. The Integrated Annual Report along with the AGM notice are being emailed to the Shareholders of the Company on 4 September 2026, to those Members whose email IDs are registered with the Company/Depository Participant(s) as on Friday, 28 August 2026. Further the company has informed that it has fixed Monday, 21 September 2026, as the cut-off date to reckon the eligibility to vote on the e-voting platform. Further, in accordance with Regulation 36(1)(b) of the Listing Regulations, the Company has dispatched letters to Shareholders whose e-mail addresses are not registered with Company/DPs providing the weblink to access the Integrated Annual Report for FY 2025-26. This intimation is also being uploaded on Company’s website at www.asterqualitycare.com.
The above information is a part of company’s filings submitted to BSE.
Cohance Lifesciences informs about completion of USFDA inspection
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Anuh Pharma Ltd. is ₹81.10 as of 2026-09-04.
The market capitalisation of Anuh Pharma Ltd. is ₹814.22 as of 2026-09-04.
The 1-year return of Anuh Pharma Ltd. is -4.32% as of 2026-09-04.
The P/E ratio of Anuh Pharma Ltd. is 16.39 as of 2026-09-05.
The 52-week high and low of Anuh Pharma Ltd. are ₹93.00 and ₹67.00, respectively, as of 2026-09-04.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
